可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Nyk?nen AI,Tuuminen R,Lemstr?m KB.Donor simvastatin treatment and cardiac allograft ischemia/reperfusion injury[J].Trends Cardiovasc Med,2013,23(3):85-90.
[2]Guo WG,Su FF,Yuan LJ,et al.Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a[J].Clin Exp Pharmacol Physiol,2010,37(1):40-45.
[3]Hashmi S,Al-Salam S.Hypoxia-inducible factor-1 alpha in the heart:a double agent?[J].Cardiol Rev,2012, 20(6):268-273.
[4]Antonopoulos AS,Margaritis M,Lee R,et al.Statins as anti-inflammatory agents in atherogenesis:molecular mechanisms and lessons from the recent clinical trials[J].Curr Pharm Des,2012,18(11):1519-1530.
[5]Rajtík T,Carnická S,Szobi A,et al.Pleiotropic effects of simvastatin are associated with mitigation of apoptotic component of cell death upon lethal myocardial reperfusion-induced injury[J].Physiol Res, 2012,61(Suppl 2):S33-S41.
[6]Guo Y,Yang T,Lu J,et al.Rb1 postconditioning attenuates liver warm ischemia-reperfusion injury through ROS-NO-HIF pathway[J].Life Sci,2011,88(13/14):598-605.
[7]Wang X,Ma S,Qi G.Effect of hypoxia-inducible factor 1-alpha on hypoxia/reoxygenation-induced apoptosis in primary neonatal rat cardiomyocytes[J].Biochem Biophys Res Commun,2012,417(4):1227-1234.